The functional and financial impact of isolated and recurrent dislocation after total hip arthroplasty

Matthew Abdel, M. B. Cross, A. T. Yasen, F. S. Haddad

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The aims of this study were to determine the functional impact and financial burden of isolated and recurrent dislocation after total hip arthroplasty (THA). Our secondary goal was to determine whether there was a difference between patients who were treated nonoperatively and those who were treated operatively. We retrospectively reviewed 71 patients who had suffered dislocation of a primary THA. Their mean age was 67 years (41 to 92) and the mean follow-up was 3.8 years (2.1 to 8.2). Because patients with recurrent dislocation were three times more likely to undergo operative treatment (p < 0.0001), they ultimately had a significantly higher mean Harris Hip Score (HHS) (p = 0.0001), lower mean Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores (p = 0.001) and a higher mean SF-12 score (p < 0.0001) than patients with a single dislocation. Likewise, those who underwent operative treatment had a higher mean HHS (p < 0.0001), lower mean WOMAC score (p < 0.0001) and a higher mean SF-12 score (p < 0.0001) than those who were treated non-operatively. Recurrent dislocation and operative treatment increased costs by 300% (£11 456; p < 0.0001) and 40% (£5217; p < 0.0001), respectively. The operative treatment of recurrent dislocation results in significantly better function than non-operative management. Moreover, the increase in costs for operative treatment is modest compared with that of non-operative measures.

Original languageEnglish (US)
Pages (from-to)1046-1049
Number of pages4
JournalBone and Joint Journal
Volume97-B
Issue number8
DOIs
StatePublished - Aug 1 2015

Fingerprint

Arthroplasty
Hip
Health Care Costs
Ontario
Arthritis
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

The functional and financial impact of isolated and recurrent dislocation after total hip arthroplasty. / Abdel, Matthew; Cross, M. B.; Yasen, A. T.; Haddad, F. S.

In: Bone and Joint Journal, Vol. 97-B, No. 8, 01.08.2015, p. 1046-1049.

Research output: Contribution to journalArticle

Abdel, Matthew ; Cross, M. B. ; Yasen, A. T. ; Haddad, F. S. / The functional and financial impact of isolated and recurrent dislocation after total hip arthroplasty. In: Bone and Joint Journal. 2015 ; Vol. 97-B, No. 8. pp. 1046-1049.
@article{9a3caee5f6e74a09867b46d5d0f8db38,
title = "The functional and financial impact of isolated and recurrent dislocation after total hip arthroplasty",
abstract = "The aims of this study were to determine the functional impact and financial burden of isolated and recurrent dislocation after total hip arthroplasty (THA). Our secondary goal was to determine whether there was a difference between patients who were treated nonoperatively and those who were treated operatively. We retrospectively reviewed 71 patients who had suffered dislocation of a primary THA. Their mean age was 67 years (41 to 92) and the mean follow-up was 3.8 years (2.1 to 8.2). Because patients with recurrent dislocation were three times more likely to undergo operative treatment (p < 0.0001), they ultimately had a significantly higher mean Harris Hip Score (HHS) (p = 0.0001), lower mean Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores (p = 0.001) and a higher mean SF-12 score (p < 0.0001) than patients with a single dislocation. Likewise, those who underwent operative treatment had a higher mean HHS (p < 0.0001), lower mean WOMAC score (p < 0.0001) and a higher mean SF-12 score (p < 0.0001) than those who were treated non-operatively. Recurrent dislocation and operative treatment increased costs by 300{\%} (£11 456; p < 0.0001) and 40{\%} (£5217; p < 0.0001), respectively. The operative treatment of recurrent dislocation results in significantly better function than non-operative management. Moreover, the increase in costs for operative treatment is modest compared with that of non-operative measures.",
author = "Matthew Abdel and Cross, {M. B.} and Yasen, {A. T.} and Haddad, {F. S.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1302/0301-620X.97B8.34952",
language = "English (US)",
volume = "97-B",
pages = "1046--1049",
journal = "Bone and Joint Journal",
issn = "2049-4394",
publisher = "British Editorial Society of Bone and Joint Surgery",
number = "8",

}

TY - JOUR

T1 - The functional and financial impact of isolated and recurrent dislocation after total hip arthroplasty

AU - Abdel, Matthew

AU - Cross, M. B.

AU - Yasen, A. T.

AU - Haddad, F. S.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - The aims of this study were to determine the functional impact and financial burden of isolated and recurrent dislocation after total hip arthroplasty (THA). Our secondary goal was to determine whether there was a difference between patients who were treated nonoperatively and those who were treated operatively. We retrospectively reviewed 71 patients who had suffered dislocation of a primary THA. Their mean age was 67 years (41 to 92) and the mean follow-up was 3.8 years (2.1 to 8.2). Because patients with recurrent dislocation were three times more likely to undergo operative treatment (p < 0.0001), they ultimately had a significantly higher mean Harris Hip Score (HHS) (p = 0.0001), lower mean Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores (p = 0.001) and a higher mean SF-12 score (p < 0.0001) than patients with a single dislocation. Likewise, those who underwent operative treatment had a higher mean HHS (p < 0.0001), lower mean WOMAC score (p < 0.0001) and a higher mean SF-12 score (p < 0.0001) than those who were treated non-operatively. Recurrent dislocation and operative treatment increased costs by 300% (£11 456; p < 0.0001) and 40% (£5217; p < 0.0001), respectively. The operative treatment of recurrent dislocation results in significantly better function than non-operative management. Moreover, the increase in costs for operative treatment is modest compared with that of non-operative measures.

AB - The aims of this study were to determine the functional impact and financial burden of isolated and recurrent dislocation after total hip arthroplasty (THA). Our secondary goal was to determine whether there was a difference between patients who were treated nonoperatively and those who were treated operatively. We retrospectively reviewed 71 patients who had suffered dislocation of a primary THA. Their mean age was 67 years (41 to 92) and the mean follow-up was 3.8 years (2.1 to 8.2). Because patients with recurrent dislocation were three times more likely to undergo operative treatment (p < 0.0001), they ultimately had a significantly higher mean Harris Hip Score (HHS) (p = 0.0001), lower mean Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores (p = 0.001) and a higher mean SF-12 score (p < 0.0001) than patients with a single dislocation. Likewise, those who underwent operative treatment had a higher mean HHS (p < 0.0001), lower mean WOMAC score (p < 0.0001) and a higher mean SF-12 score (p < 0.0001) than those who were treated non-operatively. Recurrent dislocation and operative treatment increased costs by 300% (£11 456; p < 0.0001) and 40% (£5217; p < 0.0001), respectively. The operative treatment of recurrent dislocation results in significantly better function than non-operative management. Moreover, the increase in costs for operative treatment is modest compared with that of non-operative measures.

UR - http://www.scopus.com/inward/record.url?scp=84938353377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938353377&partnerID=8YFLogxK

U2 - 10.1302/0301-620X.97B8.34952

DO - 10.1302/0301-620X.97B8.34952

M3 - Article

C2 - 26224819

AN - SCOPUS:84938353377

VL - 97-B

SP - 1046

EP - 1049

JO - Bone and Joint Journal

JF - Bone and Joint Journal

SN - 2049-4394

IS - 8

ER -